Page 3 - Brigham Hyde News Today

Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced

An innovative, newly devised AI model can accurately detect eye conditions, such as glaucoma, and could, in future, help speed up the detection of systemic health issues, such as Parkinson's disease.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Atropos Health has completed strategic financing from Presidio Ventures, the venture arm of Sumitomo Corporation, Samsung Next...

The company will use the funds to expand internationally, initially focused on the Japanese and Brazilian markets.

Autumn Communications was the incumbent on the account, which switched hands in August.

Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis.

Jack O'Brien interviews Atropos Health CEO and co-founder Brigham Hyde, Lecia Bushak gives a rundown on some newly introduced bills aimed at reining in fentanyl and Jack reports on a skincare brand's apology over a TikTok influencer promo.

Real-time data, real-world data, and AI are improving healthcare data management, accelerating medical research and improving care.

Atropos Health — a company that delivers clinical data to physicians at the point of care to help them treat complex patients — recently launched a clinical advisory board and new evidence network. Both announcements are meant to enhance the credibility and transparency of its physician consult platform, CEO Brigham Hyde said at ViVE in Nashville.